Phillips A - Search Results

1

British HIV Association guidelines for the treatment of HIV-1-positive adults with antiretroviral therapy 2012.

Williams I, Churchill D, Anderson J, Boffito M, Bower M, Cairns G, Cwynarski K, Edwards S, Fidler S, Fisher M, Freedman A, Geretti AM, Gilleece Y, Horne R, Johnson M, Khoo S, Leen C, Marshall N, Nelson M, Orkin C, Paton N, Phillips A, Post F, Pozniak A, Sabin C, Trevelion R, Ustianowski A, Walsh J, Waters L, Wilkins E, Winston A, Youle M. Williams I, et al. Among authors: phillips a. HIV Med. 2012 Sep;13 Suppl 2:1-85. doi: 10.1111/j.1468-1293.2012.01029.x. HIV Med. 2012. PMID: 22830364 Free article.

2

Laboratory control values for CD4 and CD8 T lymphocytes. Implications for HIV-1 diagnosis.

Bofill M, Janossy G, Lee CA, MacDonald-Burns D, Phillips AN, Sabin C, Timms A, Johnson MA, Kernoff PB. Bofill M, et al. Among authors: phillips an. Clin Exp Immunol. 1992 May;88(2):243-52. doi: 10.1111/j.1365-2249.1992.tb03068.x. Clin Exp Immunol. 1992. PMID: 1349272 Free PMC article.

3

Immunodeficiency and the risk of death in HIV infection.

Phillips AN, Elford J, Sabin C, Bofill M, Janossy G, Lee CA. Phillips AN, et al. JAMA. 1992 Nov 18;268(19):2662-6. JAMA. 1992. PMID: 1359163

4

Percentage of CD4 lymphocytes and risk of AIDS.

Mocroft A, Sabin CA, Phillips AN. Mocroft A, et al. Among authors: phillips an. JAMA. 1995 Dec 20;274(23):1836. JAMA. 1995. PMID: 7500527 No abstract available.

5

Markers of immune cell activation and disease progression. Cell activation in HIV disease.

Peakman M, Mahalingam M, Pozniak A, McManus TJ, Phillips AN, Vergani D. Peakman M, et al. Among authors: phillips an. Adv Exp Med Biol. 1995;374:17-26. doi: 10.1007/978-1-4615-1995-9_2. Adv Exp Med Biol. 1995. PMID: 7572390

6

The effect of CMV infection on progression of human immunodeficiency virus disease is a cohort of haemophilic men followed for up to 13 years from seroconversion.

Sabin CA, Phillips AN, Lee CA, Janossy G, Emery V, Griffiths PD. Sabin CA, et al. Among authors: phillips an. Epidemiol Infect. 1995 Apr;114(2):361-72. doi: 10.1017/s095026880005799x. Epidemiol Infect. 1995. PMID: 7705496 Free PMC article.

7

The association between HIV phenotype, virus burden, codon 215 mutation and CD4 cell decline.

Sabin CA, Mocroft AA, Phillips AN. Sabin CA, et al. Among authors: phillips an. J Acquir Immune Defic Syndr Hum Retrovirol. 1995 May 1;9(1):101-2. doi: 10.1097/00042560-199505010-00018. J Acquir Immune Defic Syndr Hum Retrovirol. 1995. PMID: 7712228 No abstract available.

8

Cervical abnormality and sexually transmitted disease screening in human immunodeficiency virus-positive women.

Olaitan A, Mocroft A, McCarthy K, Phillips A, Reid W, Johnson M. Olaitan A, et al. Among authors: phillips a. Obstet Gynecol. 1997 Jan;89(1):71-5. doi: 10.1016/s0029-7844(96)00377-8. Obstet Gynecol. 1997. PMID: 8990441

9

Early assessment of anti-HIV drug efficacy.

Paddam L, Sabin C, Lepri AC, Phillips A. Paddam L, et al. Among authors: phillips a. Lancet. 2002 May 11;359(9318):1696-7; author reply 1697. doi: 10.1016/S0140-6736(02)08571-9. Lancet. 2002. PMID: 12020557 No abstract available.

10

Definition of loss of virological response in trials of antiretroviral drugs.

Staszewski S, Sabin C, Dauer B, Lepri AC, Phillips A. Staszewski S, et al. Among authors: phillips a. AIDS. 2003 Sep 5;17(13):1997-8. doi: 10.1097/00002030-200309050-00024. AIDS. 2003. PMID: 12960838

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

4,632 results

Search Page